Aprea Therapeutics, Inc. Financial Ratios — APRE Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-34.21	-28.11	-47.24	-49.63	-259.05	-54.11	-55.58	-63.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	1	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	-0.02	-0.01	-0.01	- -	- -	- -	- -
Net Debt/EBITDA	1.54	3.98	4.43	1.69	1.43	0.77	1.4	1.6	1.1
Total Debt/EBIT	- -	- -	-0.02	-0.01	-0.01	- -	- -	- -	- -
Net Debt/EBIT	1.54	3.98	4.4	1.69	1.42	0.77	1.4	1.6	1.1
EBITDA to Interest Expense	-1,056,296.2	-90,555.42	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-1,056,296.2	-90,575.76	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-1,056,825	-90,601.12	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-189.05	-94.42	-67.74	-155.15	-318.76	-974.25	-1,360.16	-1,338.8	-2,093.92
Long-Term Debt/Equity (%)	- -	- -	0.24	0.1	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.34	-0.05	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.23	0.08	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	-0.61	-0.23	-0.11	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.41	0.36	0.34	- -	- -	- -	- -
Net Debt to Equity	68.23	127.68	-104.7	-115.02	-107.21	-112.26	-127.45	-118.35	-117.34
Net Debt/Capital (%)	34.26	51.3	59.12	38.26	22.68	8.92	6.55	6.64	4.19
EBITDA	-16	-16	-29	-53	-37	-37	-15	-14	-13
EBITDA-CapEx	-16	-16	-29	-53	-37	-37	-16	-14	-13
Operating Income (Loss)	-16	-16	-30	-53	-37	-37	-15	-14	-13

Liquidity (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	5.67	13.49	14.36	5.81	7.25	8.99	4.93	6.8	5.28
Current Ratio	5.75	13.56	14.68	6.03	7.73	9.42	5.14	7.01	5.63
Quick Ratio	5.67	13.49	14.36	5.81	7.25	8.99	4.93	6.8	5.28
CFO/Avg Current Liab	- -	-3.33	-3.83	-3.43	-3.33	-4.76	-3.21	-3.5	-4.21
Common Equity/Total Assets	-189.05	-94.42	-67.74	-155.15	-318.76	-974.25	-1,360.16	-1,338.8	-2,093.92
Long-Term Debt/Equity (%)	- -	- -	0.24	0.1	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.34	-0.05	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.23	0.08	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	-0.61	-0.23	-0.11	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.41	0.36	0.34	- -	- -	- -	- -
CFO/Total Liabilities	-23.13	-12.98	-285.22	-271.27	-515.08	-554.31	-213.77	-290.17	-369.29
CFO/CapEx	- -	-4,119.46	-864.33	-1,625.99	- -	- -	-130.81	-875.87	- -
Altman's Z-Score	-3.78	-1.04	17.08	0.99	-0.59	-15.2	-18.55	-17.37	-31.09

Working Capital (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	275	104	61	11	17	18	- -
- Cash & Cash Equivalents	24	66	130	89	53	29	22	23	15
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	- -	- -	- -	- -	- -	- -
Enterprise Value	-24	-66	146	15	8	-18	-5	-5	-15
Total Capital	-47	-62	-90	-144	-181	-294	-308	-321	-334
Total Debt/Capital (%)	- -	- -	-0.61	-0.23	-0.11	- -	- -	- -	- -
Total Debt / EV	- -	- -	- -	0.02	0.02	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	275	104	61	11	17	18	- -
Diluted Enterprise Value	-24	-66	146	15	8	-18	-5	-5	-15
EV per Share	- -	- -	486.17	14.47	7.71	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-16	-16	-29	-53	-37	-37	-15	-14	-13
TTM Operating Income	-16	-16	-30	-53	-37	-37	-15	-14	-13
TTM Cash Flow to Firm	-14	-15	-27	-42	-38	-25	-12	-14	-13
TTM Free Cash Flow to Firm	-14	-15	-27	-42	-38	-25	-12	-14	-13

Multiples (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-10.33	-2.49	-1.62	-0.44	-1.41	-1.34	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-24	-66	146	15	8	-18	-5	-5	-15
Low Price	- -	- -	302	94.6	55.76	6.08	2.78	2.15	0.84
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.89	-11.96	-2.78	-0.34	-1.19	-1.93	- -
Price/Earnings High	- -	- -	-11.36	-18.18	-4.85	-0.94	-3.04	-3.76	- -
Price/Earnings Low	- -	- -	-3.23	-1.87	-1.6	-0.09	-0.7	-0.91	- -
Price/Book Value	- -	- -	-3.04	-0.72	-0.34	-0.04	-0.06	-0.06	- -
Price/Book Value Average	- -	- -	-1.83	-4.44	-0.57	-0.13	-0.06	-0.08	- -
Price/Book Value High	- -	- -	-3.52	-6.75	-0.99	-0.36	-0.14	-0.15	- -
Price/Book Value Low	- -	- -	-1	-0.69	-0.33	-0.03	-0.03	-0.04	- -
Price/Tangible Book Value	- -	- -	2.22	1.34	1.23	0.43	1	0.94	- -
Price/Tangible Book Value Average	- -	- -	1.33	8.26	2.08	1.49	1	1.3	- -
Price/Tangible Book Value High	- -	- -	2.57	12.56	3.64	4.15	2.56	2.53	- -
Price/Tangible Book Value Low	- -	- -	0.73	1.29	1.2	0.39	0.59	0.61	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-10.31	-2.49	-1.62	-0.44	-1.4	-1.34	- -
Price/Cash Flow Average	- -	- -	-6.19	-15.29	-2.74	-1.52	-1.39	-1.84	- -
Price/Cash Flow High	- -	- -	-11.94	-23.26	-4.78	-4.25	-3.56	-3.6	- -
Price/Cash Flow Low	- -	- -	-3.39	-2.39	-1.57	-0.4	-0.83	-0.87	- -
Price/Free Cash Flow Average	- -	- -	-6.2	-15.3	-2.74	-1.52	-1.4	-1.85	- -
Price/Free Cash Flow High	- -	- -	-11.95	-23.27	-4.78	-4.25	-3.59	-3.6	- -
Price/Free Cash Flow Low	- -	- -	-3.4	-2.39	-1.57	-0.4	-0.83	-0.87	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	1.54	3.98	-1.22	-10.47	-1.35	-0.25	0.3	-0.15	1.1
EV/EBITDA High	1.54	3.98	-6.44	-16.8	-3.42	-2.09	-1.41	-1.81	1.1
EV/EBITDA Low	1.54	3.98	1.32	-0.21	-0.17	0.5	0.75	0.77	1.1
EV/EBIT Average	1.54	3.98	-1.21	-10.43	-1.34	-0.25	0.3	-0.15	1.1
EV/EBIT High	1.54	3.98	-6.41	-16.73	-3.4	-2.08	-1.41	-1.81	1.1
EV/EBIT Low	1.54	3.98	1.32	-0.21	-0.17	0.5	0.75	0.77	1.1
Last Price	- -	- -	917.8	98.4	57.4	6.62	4.7	3.29	0.85
High Price	- -	- -	1,062.2	920	169.2	64.2	12	8.85	5
Enterprise Value Average	-24	-66	36	551	50	9	-5	2	-15
Enterprise Value High	-24	-66	189	883	127	78	22	26	-15
Enterprise Value Low	-24	-66	-39	11	6	-19	-12	-11	-15

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	1	1	1	1	1	3	4	5	8
Diluted Weighted Avg Shares	1	1	- -	1	1	2	4	6	- -
Basic Weighted Avg Shares	1	1	- -	1	1	2	4	6	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-22.51	-23.42	-97.87	-49.76	-34.93	-22.44	-4.27	-2.59	- -
Operating Income per Share	-22.52	-23.43	-98.44	-49.98	-35.18	-22.55	-4.28	-2.6	- -
Basic EPS, GAAP	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	- -
Basic EPS from Cont Ops	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	- -
Diluted EPS, GAAP	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	- -
Diluted EPS from Cont Ops	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-19.9	-21.67	-88.99	-39.56	-35.41	-15.09	-3.37	-2.46	- -
Free Cash Flow per Basic Share	-19.9	-21.67	-89.1	-39.58	-35.41	-15.09	-3.39	-2.46	- -
Cash & Equivalents per Share	34.67	93.32	433.45	84.24	49.87	17.37	5.97	4.15	- -
Book Value per Share	-66.52	-88.58	-301.57	-136.26	-170.19	-177.3	-85.16	-58.27	- -
Tangible Book Value per Share	-50.82	-73.09	413.97	73.24	46.51	15.48	4.69	3.5	- -

Aprea Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)